BlackRock »

4d Molecular Therapeutics In shares owned by BlackRock

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $53M 4.9M 10.81

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
BlackRock
VR Adviser
Goldman Sachs Group
Deep Track Capital
Henderson Group
Vanguard Group
State Street Corporation
Assenagon Asset Management
Novo A/S
Morgan Stanley
Redmile Group
Braidwell

View all funds holding 4d Molecular Therapeutics In